North American Report

Adult Growth Hormone Deficiency Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

 Breaking News
  • No posts were found

Adult Growth Hormone Deficiency Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working

October 20
03:34 2021
Adult Growth Hormone Deficiency Market: Analysis of Epidemiology, Pipeline Products, and Key Companies Working
DelveInsight Business Research LLP
DelveInsight’s “Adult Growth Hormone Deficiency (AGHD) – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Adult Growth Hormone Deficiency (AGHD), historical and forecasted epidemiology as well as the Adult Growth Hormone Deficiency (AGHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Adult Growth Hormone Deficiency – Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Adult Growth Hormone Deficiency – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Adult Growth Hormone Deficiency, historical and forecasted epidemiology as well as the Adult Growth Hormone Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Adult Growth Hormone Deficiency Market Report:

  1. According to D B Allen et al., about 15%-20% of the cases represent the transition of childhood GH deficiency into adulthood.

  2. As per Jana Bujanova et al., the estimates the prevalence of AGHD in the UK is approximately 1 in 10 000 (a total of approximately 6380 patients). If Childhood-onset GH deficiency is added to this number then prevalence is 1 in 10 000 to 1 in 3500.

  3. According to Growth hormone Foundation estimates, more than 50,000 adults in the United States are growth hormone deficient, and 6,000 new cases are reported each year, including GHD children who transition to GHD as an adult.

Key benefits of the report:

  1. Adult Growth Hormone Deficiency market report covers a descriptive overview and comprehensive insight of the Adult Growth Hormone Deficiency Epidemiology and Adult Growth Hormone Deficiency  market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

  2. The Adult Growth Hormone Deficiency market report provides insights on the current and emerging therapies.

  3. Adult Growth Hormone Deficiency market report provides a global historical and forecasted market covering drug outreach in 7MM.

  4. The Adult Growth Hormone Deficiency market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Adult Growth Hormone Deficiency market.

Got queries? Click here to know more about the Adult Growth Hormone Deficiency Market Landscape.

Adult Growth Hormone Deficiency Overview

Adult-Onset Growth Hormone Deficiency (AGHD) is a medical condition that occurs when the body does not produce enough growth hormone. It stimulates the release of another hormone called insulin-like growth factor 1, which is produced mainly by the liver. Together, these hormones produce growth in childhood and, in adult life, have widespread metabolic effects throughout the body.

Adult Growth Hormone Deficiency Market 

The dynamics of the Adult Growth Hormone Deficiency market is anticipated to change in the coming years owing to the expected launch of emerging therapies such as Ascendis Pharma, Genexine, OPKO Health, and others during the forecasted period 2018-2030.

Adult Growth Hormone Deficiency Pipeline Therapies and Key Companies 

  • TransCon hGH: Ascendis Pharma

  • HyTropin (GX-H9): Genexine

  • Somatrogon: OPKO Health

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Adult Growth Hormone Deficiency Patient Share (%) Overview at a Glance

5. Adult Growth Hormone Deficiency Market Overview at a Glance

6. Adult Growth Hormone Deficiency Disease Background and Overview

7. Adult Growth Hormone Deficiency Epidemiology and Patient Population

8. Country-Specific Patient Population of Adult Growth Hormone Deficiency 

9. Adult Growth Hormone Deficiency Current Treatment and Medical Practices

10. Unmet Needs

11. Adult Growth Hormone Deficiency Emerging Therapies

12. Adult Growth Hormone Deficiency Market Outlook

13. Country-Wise Adult Growth Hormone Deficiency Market Analysis (2018–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Adult Growth Hormone Deficiency Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Click here to read more about Adult Growth Hormone Deficiency Market Outlook 2030.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/